[{"id":"e6ba65a5-add8-46e3-92be-e691b36ec343","acronym":"","url":"https://clinicaltrials.gov/study/NCT01426828","created_at":"2021-01-18T05:53:17.271Z","updated_at":"2024-07-02T16:36:37.817Z","phase":"Phase 2","brief_title":"Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant","source_id_and_acronym":"NCT01426828","lead_sponsor":"University of Pennsylvania","biomarkers":" CD8 • CD4 • TBX21 • KLRG1","pipe":"","alterations":" ","tags":["CD8 • CD4 • TBX21 • KLRG1"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 08/01/2011","start_date":" 08/01/2011","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2020-12-04"}]